PHRMASI logo

Phaarmasia Ltd

PHRMASI·BSE·
83.00 -2.80 (-3.26%)
Market Cap61.65 Cr
PE Ratio3.40
Volume2,249
Day High - Low90.05 - 81.55
52W High-Low131.75 - 31.00
DocStoX Score
3.9/10
Poor
Fair Value
Sign in to see
ROE
12.80%
Average
P/E
3.40x
Cheap
Debt / Equity
0.05
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Poor

Price performance

Day81.55
90.05
52W31.00
131.75
DocStoX take

Supported by growth (7.0), but held back by quality (1.0).

DocStoX score

Low confidence
3.9
/10
Poor
Quality
Weak
ROE 12.8%
Valuation
Fair
P/E 3.4×
Growth
Steady
Revenue +24.2% 5Y CAGR
Risk
Elevated
D/E 0.05
Momentum
Firm
52% of 52-week range

At a glance

Market Cap
₹62 Cr
52W High / Low
₹132 / ₹31
Dividend Yield
0.00%
Promoter Holding
73.51%
EPS (TTM)
₹24.41
Book Value
₹26.15

Key highlights

  • Low leverage — D/E 0.05
  • Undemanding at 3× earnings
  • Revenue compounding 24% a year
  • Loss-making in some of the last 5 years
  • Quality is weak (1.0/10)
3 Positives3 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Phaarmasia Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.